Novozymes A/S banner

Novozymes A/S
OTC:NVZMF

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
OTC:NVZMF
Watchlist
Price: 59.65 USD
Market Cap: $24.5B

EV/IC

6.6
Current
No historical data
Comparison unavailable

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
6.6
=
Enterprise Value
$169B
/
Invested Capital
kr25.6B

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
6.6
=
Enterprise Value
$169B
/
Invested Capital
kr25.6B

Valuation Scenarios

Novozymes A/S is trading above its 3-year average

If EV/IC returns to its 3-Year Average (6.6), the stock would be worth $59.65 (0% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-84%
Maximum Upside
No Upside Scenarios
Average Downside
21%
Scenario EV/IC Value Implied Price Upside/Downside
Current Multiple 6.6 $59.65
0%
3-Year Average 6.6 $59.65
0%
5-Year Average 6.6 $59.65
0%
Industry Average 6.6 $59.65
0%
Country Average 1.1 $9.51
-84%

Forward EV/IC
Today’s price vs future invested capital

Not enough data available to calculate forward EV/IC

Peer Comparison

All Multiples
EV/IC
P/E
All Countries
Close
Market Cap EV/IC P/E
DK
Novozymes A/S
OTC:NVZMF
165.6B USD 6.6 54.8
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
13.2T JPY 3.1 27.8
US
Sherwin-Williams Co
NYSE:SHW
79.7B USD 3.8 30.7
US
Ecolab Inc
NYSE:ECL
73.5B USD 3.6 35.3
JP
Yasuhara Chemical Co Ltd
TSE:4957
10.8T JPY 0.6 10.5
CN
Wanhua Chemical Group Co Ltd
SSE:600309
280.3B CNY 1.6 21.3
CH
Givaudan SA
SIX:GIVN
25.7B CHF 2.9 24
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.3T INR 10.8 60.8
US
PPG Industries Inc
NYSE:PPG
24.2B USD 1.8 15.2
CH
Sika AG
F:SIKA
19.9B EUR 1.6 17.5
US
Albemarle Corp
NYSE:ALB
23.2B USD 1.8 -33.7
P/E Multiple
Earnings Growth PEG
DK
Novozymes A/S
OTC:NVZMF
Average P/E: 29.8
54.8
N/A N/A
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
27.8
N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
30.7
14%
2.2
US
Ecolab Inc
NYSE:ECL
35.3
14%
2.5
JP
Y
Yasuhara Chemical Co Ltd
TSE:4957
10.5
N/A N/A
CN
Wanhua Chemical Group Co Ltd
SSE:600309
21.3
10%
2.1
CH
Givaudan SA
SIX:GIVN
24
6%
4
IN
Asian Paints Ltd
NSE:ASIANPAINT
60.8
15%
4.1
US
PPG Industries Inc
NYSE:PPG
15.2
10%
1.5
CH
Sika AG
F:SIKA
17.5
8%
2.2
US
Albemarle Corp
NYSE:ALB
Negative Multiple: -33.7 N/A N/A

Market Distribution

In line with most companies in Denmark
Percentile
45th
Based on 438 companies
45th percentile
1
Low
0.1 — 0.6
Typical Range
0.6 — 1.9
High
1.9 —
Distribution Statistics
Denmark
Min 0.1
30th Percentile 0.6
Median 1.1
70th Percentile 1.9
Max 40.8

Novozymes A/S
Glance View

Market Cap
24.5B USD
Industry
Chemicals

Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly. The company’s extensive portfolio of enzymes transforms processes across a diverse array of industries, including agriculture, food and beverages, household care, and bioenergy. By engineering microorganisms to optimize yield and reduce waste, Novozymes provides solutions that both enhance product performance and support environmental goals. Revenue generation for Novozymes predominantly stems from its ability to innovate and provide proprietary solutions that businesses around the world rely on to gain a competitive edge. While enzymes in detergents simplify stain removal and enable energy-efficient washing at lower temperatures, in agriculture, Novozymes' biological solutions enhance crop yield by fostering nutrient absorption and pest resilience. This vast spectrum of applications showcases the company's deep integration into its clients' production processes, creating a stable demand. Novozymes capitalizes on its research and development prowess, ensuring a continuous flow of advanced, tailor-made bio-solutions, thereby securing long-term partnerships and a sustainable revenue stream from its global market presence.

NVZMF Intrinsic Value
Not Available
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett